Fresno, CA 的 非小細胞肺癌 臨床試驗
7 項針對 非小細胞肺癌 的研究正在 Fresno（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- Kaiser Permanente-Fresno, Fresno
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
招募中3 期
- Kaiser Permanente Fresno Orchard Plaza, Fresno
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
招募中3 期
- ClinRé 001-022 (Premier Cancer Care and Infusion Center), Fresno
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Kaiser Permanente-Fresno, Fresno
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- Kaiser Permanente-Fresno, Fresno
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
招募中
- VA Medical Center, Fresno, Fresno
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中觀察性研究
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- Kaiser Permanente-Fresno, Fresno
- Saint Agnes Medical Center, Fresno
- 還有 1 項
其他城市的 非小細胞肺癌 試驗
- Houston, TX145 項研究
- New York City, NY121 項研究
- Arlington, VA104 項研究
- Nashville, TN97 項研究
- Boston, MA90 項研究
- Los Angeles, CA87 項研究
- St. Louis, MO73 項研究
- Chicago, IL61 項研究
- Baltimore, MD60 項研究
- San Antonio, TX59 項研究
- Columbus, OH57 項研究
- Washington, DC55 項研究
Fresno 的其他研究
- 肺癌7 項研究
- 乳癌6 項研究
- 呼吸窘迫症候群6 項研究
- 急性髓系白血病5 項研究
- 偏頭痛5 項研究
- 脂肪性肝病5 項研究
- 前列腺癌5 項研究
- 卵巢癌4 項研究
- 急性肺損傷4 項研究
- 癌症（所有類型）4 項研究
- 伯基特淋巴瘤4 項研究
- 骨髓增生異常症候群3 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。